¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"malignant midline reticulosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® malignant tumor ÇÑ±Û ¾Ç¼ºÁ¾¾ç
¼³¸í   
  Á¤»óÀûÀΠÁ¶Á÷ ¼¼Æ÷°¡ °¢Á¾ ¹°¸®Àû-È­ÇÐÀû-»ý¹°ÇÐÀûÀΠ¹ß¾Ï ¹°ÁúÀÇ Àۿ렶Ǵ ¿äÀο¡ ÀÇÇØ µ¹¿¬º¯À̸¦ ÀÏÀ¸ÄѼ­ Çü¼ºµÇ´Â Á¾¾ç. ¹«Á¦ÇÑÀÇ ¼¼Æ÷ºÐ¿­·Î ¸Å¿ì ¿Õ¼ºÇϰԠÁõ½ÄÇÏ¿© ÁÖÀ§Á¶Á÷À» ÆÄ±«-ħ½ÄÇÑ´Ù. ¶Ç ¾î¶² È­Çй°ÁúÀ» ³»¾î ÁÖÀ§ÀÇ Á¶Á÷¼¼Æ÷¸¦ Ä§ÇØÇÒ »Ó¸¸ ¾Æ´Ï¶ó, Ç÷°ü ¹× ¸²ÇÁ°üÀ» µû¶ó ÀüÀÌÇÏ¿© Àü½ÅÀÇ Ä«ÄʽþƸ¦ÀÏÀ¸ÄÑ Á×À½À» ÃÊ·¡ÇÑ´Ù. »óÇǼºÀΠ°ÍÀ» ¾ÏÁ¾À̶ó Çϰí, ºñ»óÇǼºÀΠ°ÍÀ» À°Á¾À̶ó ÇÑ´Ù.
¿µ¹® malignant melanoma ÇÑ±Û ¾Ç¼ºÈæ»öÁ¾
¼³¸í   
  ÇǺο¡¼­ »ý±â´Â ¾ÏÀÇ ÀÏÁ¾. ÁַΠ¹éÀο¡°Ô È£¹ßÇϸç, 50´ë~70´ë¿¡ ¸¹ÀÌ ¹ß»ýÇϰí, ÀþÀº ¿©¼º¿¡°Ô Áõ°¡Çϴ °æÇâÀÌ ÀÖÀ¸¸ç, ÇǺξÏÁß 1~3%¸¦ Â÷ÁöÇϴ µå¹® º´À¸·Î ÇǺο͠±âŸ ±â°üÀÇ ¸á¶ó´Ñ ¼¼Æ÷°è¿¡¼­ À¯·¡Çϴ ¾Ç¼ºÁ¾¾çÀÌ´Ù.
  
  ¿øÀÎÀ¸·Î Àϱ¤³ëÃâ°ú Á÷Á¢ÀûÀΠ°ü°è°¡ ÀÖÀ¸¸ç °¡Á·Àû ¹ß»ýµµ º¼ ¼ö ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • lethal midline granuloma
    Ä¡»çÁß°£¼±À°¾ÆÁ¾, Ä¡»çÁßÀ°¾ÆÁ¾
  • midline
    Áß°£¼±
  • midline granuloma
    Ä¡»çÁß°£¼±À°¾ÆÁ¾, Ä¡»çÁßÀ°¾ÆÁ¾
  • midline incision
    Áß°£¼±Àý°³
  • midline shift
    Áß°£¼±À̵¿
  • histiocytic medullary reticulosis
    Á¶Á÷±¸¼ÓÁú±×¹°Áõ, Á¶Á÷±¸¼öÁú¸Á»óÁõ
  • leukemic reticulosis
    ¹éÇ÷º´±×¹°Áõ, ¹éÇ÷º´¸Á»óÁõ
  • lipomelanic reticulosis
    Áö¹æ»ö¼Ò±×¹°Áõ, Áö¹æ»ö¼Ò¸Á»óÁõ
  • polymorphic reticulosis
    ´ÙÇü±×¹°Áõ, ´ÙÇü¸Á»óÁõ
  • pagetoid reticulosis
    ÆÄÁ¦Æ®º´¸ð¾ç±×¹°Áõ, ÆÄÁ¦Æ®º´¸ð¾ç¸Á»óÁõ
  • reticulosis
    ±×¹°Áõ, ¸Á»óÁõ
  • choroidal malignant melanoma
    ¸Æ¶ô¸·¾Ç¼ºÈæ»öÁ¾
  • malignant
    ¾Ç¼º-
  • malignant anemia
    ¾Ç¼ººóÇ÷
  • malignant carcinoid
    ¾Ç¼ºÄ«¸£½Ã³ëÀ̵å, ¾Ç¼ºÀ¯¾ÏÁ¾
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • midline
    Áß°£¼±
  • reticulosis
    ±×¹°Áõ, ¼¼¸ÁÁõ
  • malignant
    ¾Ç¼º-
  • malignant mesothelioma
    ¾Ç¼ºÁßÇÇÁ¾
  • malignant melanoma
    ¾Ç¼ºÈæ»öÁ¾
  • neuroleptic malignant syndrome
    Ç×Á¤½Åº´¾à¹°¾Ç¼ºÁõÈıº
  • malignant tumor
    ¾Ç¼ºÁ¾¾ç
  • malignant transformation
    ¾Ç¼º¼¼Æ÷Àüȯ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • malignant mast mast reticulosis
    ¾Ç¼ººñ¸¸¼¼Æ÷±×¹°Áõ, ¾Ç¼ººñ¸¸¼¼Æ÷¼¼¸ÁÁõ
  • lethal midline granuloma
    Ä¡»çÁ߽ɼ±À°¾ÆÁ¾
  • midline granuloma
    (¢¡lethal midline granuloma) Ä¡»çÁ߽ɼ±À°¾ÆÁ¾
  • midline
    Áß°£¼±
  • midline shift
    Áß°£¼±ÀüÀ§
  • midline echo shift
    Á¤Áß¼±¸Þ¾Æ¸®º¯À§
  • epidermotrophic reticulosis
    Ç¥ÇÇÁöÇâ±×¹°Áõ, Ç¥ÇÇÁöÇâ¼¼¸ÁÁõ
  • histiocytic medullary reticulosis
    Á¶Á÷±¸¼ÓÁú±×¹°Áõ, Á¶Á÷±¸¼ÓÁú¼¼¸ÁÁõ
  • leukemic reticulosis
    ¹éÇ÷º´±×¹°Áõ, ¹éÇ÷º´¼¼¸ÁÁõ
  • lipomelanic reticulosis
    Áö¹æ»ö¼Ò±×¹°Áõ, Áö¹æ»ö¼Ò¼¼¸ÁÁõ
  • medullary histiocytic reticulosis
    ¼ÓÁúÁ¶Á÷±¸¼¼¸ÁÁõ
  • pagetoid reticulosis
    ÆÄÁ¬º´¸ð¾ç±×¹°Áõ, ÆÄÁ¬º´¸ð¾ç¼¼¸ÁÁõ
  • polymorphic reticulosis
    ´ÙÇü±×¹°Áõ, ´ÙÇü¼¼¸ÁÁõ
  • reticulosis
    ±×¹°Áõ, ¼¼¸ÁÁõ
  • malignant anemia
    (¢¡pernicious anemia) ¾Ç¼ººóÇ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • granuloma, lethal midline
    ¾Ç¼º Á߽ɼ± ¼º À°¾ÆÁ¾
  • granuloma, midline
    Áß½É(¼º) À°¾ÆÁ¾
  • Pagetoid reticulosis
    ÆÄÁ¬º´¾ç ¸Á»óÁõ
  • polymorphic reticulosis
    ´ÙÇü¸Á»óÁõ
  • polymorphic reticulosis
    ´ÙÇü¼º ¸Á»ó±¸Áõ(¼¼¸ÁÁõ)(Òýû¡àõ ØÑßÒ±¸Áõ(¼¼¸ÁÁõ))
  • Hodgkin s disease =malignant lymphoma
    È£ÁîŲº´.
  • Hodgkin s disease =malignant lymphoma
    È£ÁîŲº´.
  • granuloma, malignant
    ¾Ç¼ºÀ°¾ÆÁ¾
  • histiocytoma,malignant fibrous
    Á¶Á÷±¸Á¾, ¾Ç¼º ¼¶À¯¼º
  • histiocytosis,malignant
    ¾Ç¼º
  • hypertension,malignant
    ¾Ç¼º(äÂàõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • malignant mast cell reticulosis
    ¾Ç¼º ºñ¸¸¼¼Æ÷ ¸Á»óÁõ
  • epidermotrophic reticulosis
    Ç¥ÇÇ ÁöÇ⼺ ¸Á»óÁõ
  • histiocytic medullary reticulosis
    Á¶Á÷±¸¼º ¼öÁú¸Á»óÁõ.
  • histiocytic medullary reticulosis
    Á¶Á÷±¸ ¼öÁú ¸Á»óÁõ
  • histiocytic medullary reticulosis
    Á¶Á÷±¸¼º ¼öÁú¸Á»óÁõ
  • leukemic reticulosis
    ¹éÇ÷º´¼º ¼¼¸ÁÁõ(?ËÛËÎÌ¡).
  • lipomelanic reticulosis
    Áö¹æ »ö¼Ò¼º ¸Á»óÁõ
  • medullary reticulosis, histiocytic
    ¼öÁú¼¼¸ÁÁõ(¸Á»óÁõ)(¡­á¬ØÑñø(ØÑßÒñø), Á¶Á÷±¸¼º(ðÚòÄϰà÷)
  • polymorphic reticulosis
    ´ÙÇü¸Á»óÁõ
  • polymorphic reticulosis
    ´ÙÇü¼º ¸Á»ó±¸Áõ(¼¼¸ÁÁõ)(Òýû¡àõ ØÑßÒ±¸Áõ(¼¼¸ÁÁõ))
  • reticulosis
    ¼¼¸ÁÁõ(á¬ØÑñø)
  • reticulosis, histiocytic medullary
    Á¶Á÷±¸¼º¼öÁú¼¼¸ÁÁõ(¼öÁú¸Á»óÁõ)(ðÚòÄϰà÷âËòõá¬ØÑñø(âËòõØÑßÒñø))
  • sinus reticulosis
    µ¿Ä«Å¸¸£, µ¿¼¼¸ÁÁõ(÷ÓᬠØÑñø).
  • sinus reticulosis
    µ¿Ä«Å¸¸£(Ôס­), µ¿¼¼¸ÁÁõ(÷Óá¬ØÑñø)
  • flap, midline forehead
    Áß¾ÓÀüµÎÇÇÆÇ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reticulosis
    ¼¼¸ÁÁõ
  • midline
    Á߽ɼ±
  • midline echo
    Á¤Áß¼±¿¡ÄÚ
  • midline echo shift
    Á¤Áß¼±¿¡ÄÚº¯À§
  • midline granuloma
    Á߽ɼ±À°¾ÆÁ¾
  • midline shifting
    Á¤Áß¼±º¯À§
  • off-midline
    Áß¾Ó¼±ÀÌÅ»
  • malignant
    ¾Ç¼ºÀÇ
  • malignant adenoma
    ¾Ç¼º¼±Á¾
  • malignant cachexia
    ¾Ç¼º¾Ç¾×Áú
  • malignant change
    ¾Ç¼ºº¯È­
  • malignant degeneration
    ¾Ç¼ºÈ­
  • malignant granuloma
    ¾Ç¼ºÀ°¾ÆÁ¾
  • malignant hypertension
    ¾Ç¼º°íÇ÷¾ÐÁõ
  • malignant neoplasm
    ¾Ç¼º½Å»ý¹°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MH malignant histiocytosis; malignant hyperpyrexia; malignant hypertension; malignant hyperthermia; mam...
MHS major histocompatibility system; malignant hyperthermia in swine; malignant hyperthermia syndrome; m...
ML Licentiate in Medicine; Licentiate in Midwifery; malignant lymphoma; marked latency; maximum likelih...
HMR histiocytic medullary reticulosis
LFR lymphoid follicular reticulosis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MMR Midline malignant reticulosis
HMR Histiocytic medullary reticulosis
PR Polymorphic reticulosis
CMM Cutaneous malignant melanoma
DMM Desmoplastic Malignant Melanoma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Omega attachment

    omemtulum

    Omenns syndrome : µ¿ÀǾî=histiocytic medullary reticulosis.

    omental

    ´ë¸ÁÀÇ
  • lethal midline granuloma
    Ä¡»ç Á߽ɼ± À°¾ÆÁ¾, ¾Ç¼º Á¤Áß À°¾ÆÁõ
    ±«Àú¼º ºñ¿°.
  • midline
    Á᫐ ¼±, Á¤Áß ¼±
  • midline displacement
    Á¤Áß¼± º¯À§
  • midline echo shift
    Á¤Áß¼± ¿¡ÄÚ º¯À§
  • midline lethal granuloma
    Ä¡»ç Á¤Áß À°¾ÆÁ¾
  • midline of teeth
    Ä¡¾ÆÀÇ Á¤Áß¼±
    »óÇÏ¾Ç Ä¡±ÃÀÇ ÁßÀýÄ¡µé »çÀÌ¿¡ ÀÖ´Â Ä¡°£ Á¢ÃË ºÎÀ§.
  • borderline malignant epithelial ovarian neoplasms
    °æ°è¼º »óÇǼº ³­¼Ò Á¾¾ç
  • disseminated malignant neoplasm
    ÆÛÁ® ÀÖ´Â ¾Ï
  • jaw,nonodontogenic malignant tumor
    ºñÄ¡¾Æ¼º ¾Ç¼º Á¾¾ç
  • malignant
    ¾Ç¼º, ¾Ç¼ºÀÇ
    Á¡Â÷ÀûÀ¸·Î ³ªºüÁ®¼­ Á×À½¿¡ À̸£°Ô ÇÏ´Â. ÅðÇ༺ ħÀ±, ÀüÀÌÀÇ ¼ºÁúÀ» °¡Áö´Â Á¾¾ç¿¡ »ç¿ëµÈ´Ù.
  • malignant adenoma
    ¾Ç¼º ¼±Á¾
  • malignant anthrax
    ¾Ç¼º źÀú
  • malignant cachexia
    ¾Ç¼º ¾Ç¾×Áú
  • malignant carcinoid tumor
    ¾Ç¼º Ä«¸£½Ã³ëÀ̵å Á¾¾ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
malignant midline reticulosis An obsolete term for polymorphic reticulosis
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
midline malignant reticulosis granuloma Destruction of the nasal septum, hard palate, lateral nasal walls, paranasal sinuses, skin of the face, orbit and nasopharynx by an inflammatory infiltrate with atypical lymphocytic and histiocytic cells; presumably a form of lymphoma in most cases.
An obsolete term for polymorphic reticulosis.
Synonym: granuloma gangrenescens, malignant granuloma, midline malignant reticulosis granuloma.
(05 Mar 2000)
benign inoculation reticulosis <disease> A self-limiting bacterial infection of the regional lymph nodes (lymphadenitis) caused by afipia felis, a gram-negative bacterium recently identified as bartonella henselae.
It usually arises one or more weeks following a feline scratch, with raised inflammatory nodules at the site of the scratch being the primary symptom. It results in tender and enlarged lymph glands above the site of injury.
A chronic benign adenopathy, especially in children and young adults, commonly associated with a recent cat scratch or bite and caused by bacteria including Bartonella henselae and Alipia felis; the lymphadenopathy usually resolves spontaneously within a period of several months, but complications involving central nervous system, liver, spleen, lung, and skin have been seen.
Synonym: benign inoculation lymphoreticulosis, benign inoculation reticulosis, cat-scratch fever, regional granulomatous lymphadenitis.
(05 Mar 2000)
pagetoid reticulosis A benign localised form of lymphoma with solitary or closely grouped cutaneous tumours consisting of predominantly epidermal infiltration of mononuclear cells resembling those found in mycosis fungoides.
Synonym: pagetoid reticulosis.
(05 Mar 2000)
reticulosis 1. An increase in histiocytes, monocytes, or other reticuloendothelial elements.
2. Obsolete term for lymphoma.
Origin: reticulo-+ G. -osis, condition
(05 Mar 2000)
polymorphic reticulosis A necrotizing lymphoproliferative lesion with a predilection for the upper respiratory tract. Previously called lethal midline granuloma or malignant midline reticulosis. Treatment is irradiation.
(05 Mar 2000)
leukaemic reticulosis Cancer of the blood due to proliferation of cells of the monocyte series.
Origin: Gr. Haima = blood
(13 Nov 1997)
lipomelanic reticulosis Enlargement of lymph nodes, with proliferation of pale-staining interdigitating reticulum cells and macrophages containing fat and melanin; secondary to various forms of dermatitis.
Synonym: dermatopathic lymphadenitis, lipomelanic reticulosis.
(05 Mar 2000)
granuloma, lethal midline A non-neoplastic disease of unknown aetiology beginning with inflammation, ulceration, and perforation of nose and palate and progressing to gradual destruction of midline facial structures.
(12 Dec 1998)
midline <dentistry> A plane through the very centre of your mouth perpendicular to your nose.
(08 Jan 1998)
midline closure defects <radiology> Anencephaly, encephalocele, 70% occipital, 20% parietal or frontal, 10% basal, agenesis of corpus callosum associated with increased alpha-fetoprotein.
(12 Dec 1998)
midline granulomatosis Wegener's granulomatosis or midline granulomatosis is a rare disorder characterised by chronic tissue inflammation (due to the inflammation of blood vessels) and granuloma (aggregates of cells) formation in the nasal passages, lungs and kidneys.
(27 Sep 1997)
midline incision A vertical abdominal incision placed in the midline aponeurosis between the two sheaths of the rectus muscles of the abdomen.
(05 Mar 2000)
midline myelotomy Section of the midline transverse fibres of the spinal cord for the treatment of intractable pain.
Synonym: commissural myelotomy, commissurotomy.
(05 Mar 2000)
lethal midline granuloma Destruction of the nasal septum, hard palate, lateral nasal walls, paranasal sinuses, skin of the face, orbit and nasopharynx by an inflammatory infiltrate with atypical lymphocytic and histiocytic cells; presumably a form of lymphoma in most cases.
An obsolete term for polymorphic reticulosis.
Synonym: granuloma gangrenescens, malignant granuloma, midline malignant reticulosis granuloma.
(05 Mar 2000)
cancer, malignant melanoma A skin cancer that begins in cells called melanocytes that can grow together to form benign (not cancerous) moles. A change in size, shape, or colour of a mole can be a sign of melanoma. Melanoma can be cured if detected early, before spread (metastasis) to other areas of the body. Diagnosis is confirmed with a biopsy of the abnormal skin. Sun exposure can cause skin damage that can lead to melanoma.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • midline
    (½Åü µîÀÇ) Á߽ɼ±
  • malignant
    ¾ÇÀǸ¦ ǰÀº; ¾Ç¼ºÀÇ; ¹ÝÇ×ÀÚ
  • malignant
    À¯ÇØÇÑ;¾Ç¼ºÀÇ;¾ÇÀǸ¦ ǰÀº;... (¿µ»ç) Charles I ½Ã´ëÀÇ ¿Õ´ç¿ø
  • malignant melanoma
    ¾Ç¼º Èæ»öÁ¾
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á